Today: 9 April 2026
CBA stock rises after new wage data — what to watch before Commonwealth Bank’s Feb results

CBA stock rises after new wage data — what to watch before Commonwealth Bank’s Feb results

SYDNEY, Jan 13, 2026, 16:51 AEDT — Market has closed.

  • Shares in Commonwealth Bank climbed as Australia’s major banks gained ground amid renewed attention on interest rate forecasts
  • CBA’s wages-and-jobs tracker indicated steady pay growth amid a persistently tight labour market
  • All eyes are on the Feb. 11 earnings to glean insights into margins, costs, and credit quality

Shares of Commonwealth Bank of Australia (CBA.AX) ended Tuesday up 0.8%, buoyed by new labour-market data that continue to fuel discussion around interest rates. Investing.com Australia

This is significant since CBA has lately behaved more like a “rates stock” than usual. Even minor shifts in Reserve Bank of Australia policy expectations can jolt the sector, and with CBA’s valuation, there’s little margin for negative surprises.

Banks tend to gain when the cash rate — the RBA’s benchmark — climbs, since lending rates usually adjust quicker than deposit rates. But on the downside, funding costs increase and borrowers face more pressure, which can lead to a rise in bad debts down the line.

CBA closed at A$155.36, having fluctuated between A$154.30 and A$156.10 during the session. ANZ (ANZ.AX) climbed 1.6%, National Australia Bank (NAB.AX) jumped 1.9%, and Westpac (WBC.AX) rose 1.1%. The ASX 200 finished 0.6% higher.

The CBA Wage and Labour Insights report revealed a 0.8% rise in wages for the quarter and a 3.1% increase over the year to December. Employers added around 23,000 jobs, with unemployment steady at 4.3%.

“The labour market remains tight … and the RBA is expected to lift the cash rate in 2026,” CBA head of Australian economics Belinda Allen said in the report.

A private survey revealed consumer sentiment dropped 1.7% in January, beyond the bank’s own figures. Westpac’s Matthew Hassan highlighted a significant shift in rate expectations. Reuters

The RBA cut rates three times last year to 3.6%, but signalled the easing cycle might be done as inflation picked up, Reuters reported. CBA and NAB are now forecasting a rate hike next month. Reuters

Morgan Stanley cautioned investors to brace for another year of sharply divergent returns among the major banks, flagging CBA as a potential underperformer once more amid rising competition and its still-high valuation. Market Index

The narrative can flip fast. Should inflation or jobs figures ease and a rate hike seem less certain, the “higher-for-longer” bet on banks could unravel. That would put CBA’s valuation more in the spotlight—for all the wrong reasons.

CBA’s half-year results drop on Feb. 11, putting the spotlight on net interest margin — the spread between earnings on loans and costs on deposits and wholesale funding. Investors will also scrutinize costs, impairments, and the interim dividend plans. commbank.com.au

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Lynas Rare Earths stock rises on CEO exit plan — what ASX:LYC investors watch next
Previous Story

Lynas Rare Earths stock rises on CEO exit plan — what ASX:LYC investors watch next

NAB shares end higher as rate-hike chatter flares — what investors watch next
Next Story

NAB shares end higher as rate-hike chatter flares — what investors watch next

Go toTop